• 800 343 7475ir@bio-techne.com bio-techne.com

    • Overview
    • News / Events
    • Company Information
    • Strategy
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    Navigation

      News / Events

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents

    Press Releases

    • News / Events

    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    Nov 15, 2022

    BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY

    Nov 10, 2022

    BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE

    Nov 8, 2022

    BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE

    Nov 3, 2022

    BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE

    Nov 1, 2022

    BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND

    Nov 1, 2022

    BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS

    Oct 31, 2022

    Asuragen to Showcase Innovative Diagnostic Lab Solutions at AMP 2022 Conference

    Oct 18, 2022

    New Publication from Exosome Diagnostics Demonstrates Proof-of-Concept for Monitoring Astronaut Health in Space

    Oct 12, 2022

    BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY

    Oct 11, 2022

    BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS

    RSS
    • 1...
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • ...49
    • Email Alerts
    • Contacts
    • RSS News Feed
    Bio-Techne

    614 McKinley Place NE
    Minneapolis, MN 55413
    USA

    TEL 612 379 2956
    Toll-free 800 343 7475
    FAX 612 656 4400

    Who We Are

    • About Bio-Techne
    • Bio-Techne Brands
    • Careers
    • Corporate & Social Responsibility
    • Terms and Conditions

    Investor Relations

    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance

    Stay Connected

    • Facebook Twitter LinkedIn YouTube Instagram
    • Contact Us

    Utility Footer Menu

    • Privacy and Cookie Policy
    • Site Map
    • © Copyright 2025 Bio-Techne. All Rights Reserved.